NCIt definition : A humanized, agonistic monoclonal antibody against P selectin glycoprotein ligand-1
(PSGL-1; SELPLG; CD162), with potential immunosuppressive activity. Upon administration,
neihulizumab specifically targets and binds to CD162 expressed on activated T-lymphocytes.
This induces apoptosis of activated T-cells and reduces T-cell-mediated immune responses.
This may halt disease progression of T-cell-mediated autoimmune diseases and acute
graft-versus-host disease (GvHD).;